5% Sofpironium Bromide Gel in Japanese Patients With Primary Axillary Hyperhidrosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of 5% Sofpironium Bromide (BBI-4000) Gel in Japanese Patients With Primary Axillary Hyperhidrosis
J Dermatol 2021 Jan 07;[EPub Ahead of Print], H Yokozeki, T Fujimoto, Y Abe, M Igarashi, A Ishikoh, T Omi, H Kanda, H Kitahara, M Kinoshita, I Nakasu, N Hattori, Y Horiuchi, R Maruyama, H Mizutani, Y Murakami, C Watanabe, A Kume, T Hanafusa, M Hamaguchi, A Yoshioka, Y Egami, K Matsuo, T Matsuda, M Akamatsu, T Yorozuya, S TakayamaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.